8-Bromo-2,3-dihydro-1,4-benzodioxine-6-carbaldehyde, 97%, 50mg

(S)-6-(5-Bromo-1-((1r,4S)-4-methoxycyclohexyl)-1H-benzo[d]imidazol-2-yl)-1-(3,4-difluorophenyl)piperidin-2-one, 98%, 250mg

1-(5-Bromopyridin-2-yl)cyclobutan-1-amine, 98%, 250mg

Reaktionsgefäß, DN100, 4,0 l, zylindr.,, gradu., Temp.-Vak.-Mantel, Entleerungsventil., 1 Stück

(6-(Methoxycarbonyl)naphthalen-2-yl)boronic acid, 97%, 1g

Benzenesulfonamide, 3-cyano-N-(3-cyano-4-methyl-1H-indol-7-yl)-, 10mg

2-Propyl-1,3-thiazole-5-carbaldehyde, 97%, 250mg

2-Amino-6-cyanopyrazine, 95.0%, 5g

Benidipine Hydrochloride>98.0%(HPLC)(T)1g

3-Phenoxypyridine, 95.0%, 250mg

3-BROMO-6-(TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDINE, 97.0%, 10g

[4-(Chloromethyl)phenyl]-phenylmethanone, 95%, 5g

Methyl 2-(4-methoxyphenyl)acetate, 98.0%, 5g